🟢 CalciMedica is trading 11.17% up in pre-market as XBI rises 2.27%

CalciMedica is trading at $0.68, up 11.17% in pre-market, primarily on biotech-sector strength.

• No new CalciMedica company-specific announcement was identified for August 20, 2026; the latest update was second-quarter results and clinical developments released August 11.
• Biotech ETF XBI is up 2.27% pre-market amid optimism after positive late-stage melanoma-vaccine results from Moderna and Merck, lifting biotechnology and oncology shares broadly.
• Recent reverse-split proposals remain a potential overhang but do not explain this morning’s rise.